Hagler L, Herman RH. Oxalate metabolism .I. Am J Clin Nutr. 1973;26(7):758–65.

CAS  PubMed  Google Scholar 

Huang Y, Zhang YH, Chi ZP, Huang R, Huang H, Liu G, et al. The handling of oxalate in the body and the origin of oxalate in calcium oxalate stones. Urol Int. 2020;104(3–4):167–76.

CAS  PubMed  Google Scholar 

Robijn S, Hoppe B, Vervaet BA, D’Haese PC, Verhulst A. Hyperoxaluria: a gut-kidney axis? Kidney Int. 2011;80(11):1146–58.

CAS  PubMed  Google Scholar 

Mookadam F, Smith T, Jiamsripong P, Moustafa SE, Monico CG, Lieske JC, et al. Cardiac abnormalities in primary hyperoxaluria. Circ J. 2010;74(11):2403–9.

PubMed  PubMed Central  Google Scholar 

Khand FD, Gordge MP, Robertson WG, Noronha-Dutra AA, Hothersall JS. Mitochondrial superoxide production during oxalate-mediated oxidative stress in renal epithelial cells. Free Radical Biol Med. 2002;32(12):1339–50.

CAS  Google Scholar 

Scheid C, Koul H, Hill WA, Luber-Narod J, Kennington L, Honeyman T, et al. Oxalate toxicity in LLC-PK1 cells: role of free radicals. Kidney Int. 1996;49(2):413–9.

CAS  PubMed  Google Scholar 

Mulay SR, Honarpisheh MM, Foresto-Neto O, Shi C, Desai J, Zhao ZB, et al. Mitochondria permeability transition versus necroptosis in oxalate-induced AKI. J Am Soc Nephrol. 2019;30(10):1857–69.

CAS  PubMed  PubMed Central  Google Scholar 

Umekawa T, Chegini N, Khan SR. Oxalate ions and calcium oxalate crystals stimulate MCP-1 expression by renal epithelial cells. Kidney Int. 2002;61(1):105–12.

CAS  PubMed  Google Scholar 

Recht PA, Tepedino GJ, Siecke NW, Buckley MT, Mandeville JT, Maxfield FR, et al. Oxalic acid alters intracellular calcium in endothelial cells. Atherosclerosis. 2004;173(2):321–8.

CAS  PubMed  Google Scholar 

Crenshaw BL, McMartin KE. Calcium oxalate monohydrate is associated with endothelial cell toxicity but not with reactive oxygen species accumulation. Cardiovasc Toxicol. 2020;20(6):593–603.

CAS  PubMed  Google Scholar 

Bargagli M, Tio MC, Waikar SS, Ferraro PM. Dietary oxalate intake and kidney outcomes. Nutrients. 2020;12(9):2673.

CAS  PubMed Central  Google Scholar 

Waikar SS, Srivastava A, Palsson R, Shafi T, Hsu C-Y, Sharma K, et al. Association of urinary oxalate excretion with the risk of chronic kidney disease progression. JAMA Intern Med. 2019;179(4):542–51.

PubMed  PubMed Central  Google Scholar 

Holmes RP, Kennedy M. Estimation of the oxalate content of foods and daily oxalate intake. Kidney Int. 2000;57(4):1662–7.

CAS  PubMed  Google Scholar 

Taylor EN, Curhan GC. Oxalate intake and the risk for nephrolithiasis. J Am Soc Nephrol. 2007;18(7):2198–204.

CAS  PubMed  Google Scholar 

Ferraro PM, Bargagli M, Trinchieri A, Gambaro G. Risk of kidney stones: influence of dietary factors, dietary patterns, and vegetarian-vegan diets. Nutrients. 2020;12(3):779.

CAS  PubMed Central  Google Scholar 

Siener R, Hönow R, Voss S, Seidler A, Hesse A. Oxalate content of cereals and cereal products. J Agric Food Chem. 2006;54(8):3008–11.

CAS  PubMed  Google Scholar 

Siener R, Seidler A, Hönow R. Oxalate-rich foods. Food Sci Technol; 2020.

Mitchell T, Kumar P, Reddy T, Wood KD, Knight J, Assimos DG, et al. Dietary oxalate and kidney stone formation. Am J Physiol Ren Physiol. 2019;316(3):F409–13.

Google Scholar 

Moe SM. Rationale to reduce calcium intake in adult patients with chronic kidney disease. Curr Opin Nephrol Hypertens. 2018;27(4):251–7.

CAS  PubMed  PubMed Central  Google Scholar 

Jayedi A, Zargar MS. Dietary calcium intake and hypertension risk: a dose–response meta-analysis of prospective cohort studies. Eur J Clin Nutr. 2019;73(7):969–78.

CAS  PubMed  Google Scholar 

Lange JN, Wood KD, Mufarrij PW, Callahan MF, Easter L, Knight J, et al. The impact of dietary calcium and oxalate ratios on stone risk. Urology. 2012;79(6):1226–9.

PubMed  Google Scholar 

Holmes RP, Goodman HO, Assimos DG. Contribution of dietary oxalate to urinary oxalate excretion. Kidney Int. 2001;59(1):270–6.

CAS  PubMed  Google Scholar 

von Unruh GE, Voss S, Sauerbruch T, Hesse A. Dependence of oxalate absorption on the daily calcium intake. J Am Soc Nephrol. 2004;15(6):1567–73.

Google Scholar 

Azizi F, Zadeh-Vakili A, Takyar M. Review of rationale, design, and initial findings: tehran lipid and glucose study. Int J Endocrinol Metab. 2018;16(4 (Suppl)):e 84777.

Google Scholar 

Azizi F, Rahmani M, Emami H, Mirmiran P, Hajipour R, Madjid M, et al. Cardiovascular risk factors in an Iranian urban population: Tehran lipid and glucose study (phase 1). Soz Praventivmed. 2002;47(6):408–26.

PubMed  Google Scholar 

Azizi F, Zadeh-Vakili A, Takyar M. Review of rationale, design, and initial findings: Tehran lipid and glucose study. Int J Endocrinol Metab. 2018;16(4 Suppl):e84777.

PubMed  PubMed Central  Google Scholar 

Askari S, Asghari G, Ghanbarian A, Khazan M, Alamdari S, Azizi F. Seasonal variations of blood pressure in adults: Tehran lipid and glucose study. Arch Iran Med. 2014;17(6):441–3.

PubMed  Google Scholar 

Tohidi M, Ghasemi A, Hadaegh F, Derakhshan A, Chary A, Azizi F. Age- and sex-specific reference values for fasting serum insulin levels and insulin resistance/sensitivity indices in healthy Iranian adults: Tehran Lipid and Glucose Study. Clin Biochem. 2014;47(6):432–8.

CAS  PubMed  Google Scholar 

Hosseini-Esfahani F, Moslehi N, Asghari G, Hosseinpour-Niazi S, Bahadoran Z, Yuzbashian E, et al. Nutrition and diabetes, cardiovascular and chronic kidney diseases: findings from 20 years of the Tehran Lipid and Glucose Study. Int J Endocrinol Metab. 2018;16(4 (Suppl)):e84791.

PubMed  PubMed Central  Google Scholar 

Hosseini-Esfahani F, Jessri M, Mirmiran P, Bastan S, Azizi F. Adherence to dietary recommendations and risk of metabolic syndrome: Tehran Lipid and Glucose Study. Metabolism. 2010;59(12):1833–42.

CAS  PubMed  Google Scholar 

Mirmiran P, Esfahani FH, Mehrabi Y, Hedayati M, Azizi F. Reliability and relative validity of an FFQ for nutrients in the Tehran lipid and glucose study. Public Health Nutr. 2010;13(5):654–62.

PubMed  Google Scholar 

Asghari G, Rezazadeh A, Hosseini-Esfahani F, Mehrabi Y, Mirmiran P, Azizi F. Reliability, comparative validity and stability of dietary patterns derived from an FFQ in the Tehran Lipid and Glucose Study. Br J Nutr. 2012;108(6):1109–17.

CAS  PubMed  Google Scholar 

Shaheen N, Bari L, Mannan M. Food composition table for Bangladesh. University of Dhaka; 2013.

Yilmaz B, Sahin K, Bilen H, Bahcecioglu IH, Bilir B, Ashraf S, et al. Carotenoids and non-alcoholic fatty liver disease. Hepatobiliary Surg Nutr. 2015;4(3):161–71.

PubMed  PubMed Central  Google Scholar 

Khalili D, Azizi F, Asgari S, Zadeh-Vakili A, Momenan AA, Ghanbarian A, et al. Outcomes of a longitudinal population-based cohort study and pragmatic community trial: findings from 20 years of the Tehran Lipid and Glucose Study. Int J Endocrinol Metab. 2018; 16(4 Suppl).

Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25(6):1105–87.

CAS  PubMed  Google Scholar 

Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–12.

PubMed  PubMed Central  Google Scholar 

National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl 1):S1-266

Association AD. Standards of medical care in diabetes--2014. In: Diabetes care. 2014; pp. S14.

Hosmer DW, Lemeshow S. Applied logistic regression. 2nd ed. New York: John Wiley & Sons Inc; 2000.

Google Scholar 

Tohidi M, Hasheminia M, Mohebi R, Khalili D, Hosseinpanah F, Yazdani B, et al. Incidence of chronic kidney disease and its risk factors, results of over 10 year follow up in an Iranian cohort. PLoS ONE. 2012;7(9):e45304.

CAS  PubMed  PubMed Central  Google Scholar 

Perkins NJ, Schisterman EF. The inconsistency of “optimal” cutpoints obtained using two criteria based on the receiver operating characteristic curve. Am J Epidemiol. 2006;163(7):670–5.

PubMed  Google Scholar 

Sun K, Tang X, Song S, Gao Y, Yu H, Sun N, et al. Hyperoxalemia leads to oxidative stress in endothelial cells and mice with chronic kidney disease. Kidney Blood Press Res. 2021;46(3):377–86.

CAS  PubMed  Google Scholar 

Borghi L, Meschi T, Guerra A, Briganti A, Schianchi T, Allegri F, et al. Essential arterial hypertension and stone disease. Kidney Int. 1999;55(6):2397–406.

CAS  PubMed  Google Scholar 

Arafa A, Eshak ES, Iso H. Oxalates, urinary stones and risk of cardiovascular diseases. Med Hypotheses. 2020;137:109570.

CAS  PubMed  Google Scholar 

Ermer T, Eckardt K-U, Aronson PS, Knauf F. Oxalate, inflammasome, and progression of kidney disease. Curr Opin Nephrol Hypertens. 2016;25(4):363–71.

CAS  PubMed  PubMed Central  Google Scholar 

Khan SR. Reactive oxygen species, inflammation and calcium oxalate nephrolithiasis. Transl Androl Urol. 2014;3(3):256.

PubMed  PubMed Central  Google Scholar 

El-Saygeh S, Roese D, Moe SM. Calciphylaxis or vascular oxalosis? Clin Kidney J. 2020;14(1):435–8.

PubMed  PubMed Central  Google Scholar 

Maldonado I, Prasad V, Reginato AJ. Oxalate crystal deposition disease. Curr Rheumatol Rep. 2002;4(3):257–64.

PubMed  Google Scholar 

Kumar P, Patel M, Oster RA, Yarlagadda V, Ambrosetti A, Assimos DG, et al. Dietary oxalate loading impacts monocyte